Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/04/2010WO2010127159A2 Polymeric micelles for polynucleotide encapsulation
11/04/2010WO2010127125A1 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
11/04/2010WO2010127120A1 Method of treatment of depression
11/04/2010WO2010127108A2 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010WO2010127103A1 Stable pharmaceutical composition and methods of using same
11/04/2010WO2010127100A1 Compositions comprising an antihistamine, antitussive and decongestant in extented release formulations
11/04/2010WO2010127099A2 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
11/04/2010WO2010127096A2 Novel therapeutic treatments using centhaquin
11/04/2010WO2010127081A1 Blood parasiticide
11/04/2010WO2010127067A1 Chemical process
11/04/2010WO2010127058A1 Benzamide and naphthamide derivatives inhibiting nuclear factor- kap pa (b) - (nf-kb)
11/04/2010WO2010127033A1 Formulations of cannabidiol and methods of using the same
11/04/2010WO2010127029A1 Methods for treating or preventing ophthalmological diseases
11/04/2010WO2010126982A1 Oral compositions for skin benefits
11/04/2010WO2010126970A1 Methods for treating and preventing erectile dysfunction
11/04/2010WO2010126967A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
11/04/2010WO2010126963A1 Compositions and methods for treating and preventing overactive bladder and conditions associated therewith
11/04/2010WO2010126960A1 Pyrrolotriazine compounds
11/04/2010WO2010126953A1 Corticosteroid linked beta-agonist compounds for use in therapy
11/04/2010WO2010126922A1 Benzimidazolecarboxamides as inhibitors of fak
11/04/2010WO2010126914A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010WO2010126911A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
11/04/2010WO2010126910A1 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
11/04/2010WO2010126909A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
11/04/2010WO2010126895A1 Inhibitors of pi3 kinase and / or mtor
11/04/2010WO2010126888A1 Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
11/04/2010WO2010126881A1 Processes and intermediates
11/04/2010WO2010126857A1 Parasiticidal combinations of macrocyclic lactones and polyether antibiotics
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010126818A1 Intranasal delivery system for dantrolene
11/04/2010WO2010126745A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS
11/04/2010WO2010126743A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS
11/04/2010WO2010126719A1 Neuroprotective compounds and their use
11/04/2010WO2010126676A1 Oral formulations of bendamustine
11/04/2010WO2010126609A2 Treatment of diseases with altered smooth muscle contractility
11/04/2010WO2010126605A1 Treatment of neurodegeneration and neuroinflammation
11/04/2010WO2010126603A1 Serotonin transporter gene and treatment of alcoholism
11/04/2010WO2010126579A1 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
11/04/2010WO2010126544A1 Mast cell stabilizers to prevent or treat laminitis
11/04/2010WO2010126527A1 Methods of treating cns disorders
11/04/2010WO2010126501A1 Cannabinoid-containing compositions and methods for their use
11/04/2010WO2010126435A1 Novel galactoside inhibitors of galectins
11/04/2010WO2010126355A1 Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
11/04/2010WO2010126349A1 Soluble pharmaceutical forms of n,n'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
11/04/2010WO2010126260A2 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients
11/04/2010WO2010126179A1 Pharmaceutical composition comprising chlorine e6-folic acid conjugated compound and chitosan for treatment of cancer
11/04/2010WO2010126178A1 New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126124A1 Transdermal preparation
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010126101A1 Purine derivative and antitumor agent using same
11/04/2010WO2010126094A1 Agent for preventing non-traumatic vertebral fracture in severe osteoporosis patients which comprises eldecalcitol
11/04/2010WO2010126093A1 Agent for preventing forearm bone fracture which comprises eldecalcitol
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders
11/04/2010WO2010126036A1 Combined drug
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010126025A1 Quaternary ammonium salt compound
11/04/2010WO2010126022A1 Imidazole derivative
11/04/2010WO2010126014A1 Novel solvate crystals
11/04/2010WO2010126013A1 Method for producing olmesartan medoxomil
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125991A1 Method for control of fish parasites
11/04/2010WO2010125988A1 Method for producing tocotrienol composition
11/04/2010WO2010125985A1 Fused heterocyclic compound and use thereof
11/04/2010WO2010125891A1 Estrogen-like agonist
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125575A1 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
11/04/2010WO2010125572A1 Compressed tablets and capsules containing efavirenz
11/04/2010WO2010125541A1 A pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppressive action of aggressive agents on the skin
11/04/2010WO2010125516A1 Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
11/04/2010WO2010125472A1 Use of collinsella aerofaciens for reducing bloating
11/04/2010WO2010125469A1 Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
11/04/2010WO2010125462A2 Pentamidine combinations for treating cancer
11/04/2010WO2010125445A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010WO2010125416A1 Drug delivery to the anterior and posterior segments of the eye
11/04/2010WO2010125402A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010WO2010125390A1 Therapeutic agents 713
11/04/2010WO2010125350A1 Treatment or prophylaxis of proliferative conditions
11/04/2010WO2010125348A1 Prevention and treatment of sarcopenia
11/04/2010WO2010125343A1 Compounds for inducing cellular apoptosis
11/04/2010WO2010125340A1 Use of pufas for treating skin inflammation
11/04/2010WO2010125330A1 Use of pufas to treat nerve damage
11/04/2010WO2010125212A1 Oral ibuprofen lysinate suspension
11/04/2010WO2010125200A1 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral angents
11/04/2010WO2010125182A1 Concatamers for immunemodulation
11/04/2010WO2010125143A1 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010WO2010125136A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125134A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010125102A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
11/04/2010WO2010125101A1 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
11/04/2010WO2010125082A1 Oxazole substituted indazoles as pi3-kinase inhibitors
1 ... 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 ... 7860